Literature DB >> 24500802

Epigenetic patterns of two gene promoters (TNF-α and PON) in stroke considering obesity condition and dietary intake.

A M Gómez-Uriz1, E Goyenechea, J Campión, A de Arce, M T Martinez, B Puchau, F I Milagro, I Abete, J A Martínez, A Lopez de Munain.   

Abstract

Some causal bases of stroke remain unclear, but the nutritional effects on the epigenetic regulation of different genes may be involved. The aim was to assess the impact of epigenetic processes of human tumor necrosis factor (TNF-α) and paraoxonase (PON) promoters in the susceptibility to stroke when considering body composition and dietary intake. Twenty-four patients (12 non-stroke/12 stroke) were matched by sex (12 male/12 female), age (mean 70 ± 12 years old), and BMI (12 normal-weight/12 obese; mean 28.1 ± 6.7 kg/m(2)). Blood cell DNA was isolated and DNA methylation levels of TNF-α (-186 to +349 bp) and PON (-231 to +250 bp) promoters were analyzed by the Sequenom EpiTYPER approach. Histone modifications (H3K9ac and H3K4me3) were analyzed also by chromatin immunoprecipitation in a region of TNF-α (-297 to -185). Total TNF-α promoter methylation was lower in stroke patients (p < 0.001) and showed no interaction with body composition (p = 0.807). TNF-α and PON total methylation levels correlated each other (r = 0.44; p = 0.031), especially in stroke patients (r = 0.72; p = 0.008). The +309 CpG methylation site from TNF-α promoter was related to body weight (p = 0.027) and the region containing three CpGs (from -170 to -162 bp) to the percentage of lipid intake and dietary indexes (p < 0.05) in non-stroke patients. The methylation of PON +15 and +241 CpGs was related to body weight (p = 0.021), waist circumference (p = 0.020), and energy intake (p = 0.018), whereas +214 was associated to the quality of the diet (p < 0.05) in non-stroke patients. When comparing stroke vs non-stroke patients regarding the histone modifications analyzed at TNF-α promoter, no changes were found, although a significant association was identified between circulating TNF-α level and H3K9ac with H3K4me3. TNF-α and PON promoter methylation levels could be involved in the susceptibility to stroke and obesity outcome, respectively. The dietary intake and body composition may influence this epigenetic regulation in non-stroke patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24500802     DOI: 10.1007/s13105-014-0316-5

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  48 in total

1.  Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.

Authors:  Omana P Mathew; Kasturi Ranganna; Frank M Yatsu
Journal:  Biomed Pharmacother       Date:  2010-12       Impact factor: 6.529

Review 2.  Advances in genomic analysis of stroke: what have we learned and where are we headed?

Authors:  Matthew B Lanktree; Martin Dichgans; Robert A Hegele
Journal:  Stroke       Date:  2010-02-18       Impact factor: 7.914

3.  Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype.

Authors:  Nicholas J Timpson; Roger Harbord; George Davey Smith; Jeppe Zacho; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Hypertension       Date:  2009-05-26       Impact factor: 10.190

Review 4.  Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels.

Authors:  Ildikó Seres; László Bajnok; Mariann Harangi; Ferenc Sztanek; Peter Koncsos; György Paragh
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes.

Authors:  Feng Miao; Xiwei Wu; Lingxiao Zhang; Yate-Ching Yuan; Arthur D Riggs; Rama Natarajan
Journal:  J Biol Chem       Date:  2007-03-05       Impact factor: 5.157

6.  Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Barbara K Yoza; Jean Y-Q Hu; Sue L Cousart; Charles E McCall
Journal:  J Biol Chem       Date:  2007-07-23       Impact factor: 5.157

7.  TNF-alpha promoter methylation as a predictive biomarker for weight-loss response.

Authors:  Javier Campión; Fermin I Milagro; Estibaliz Goyenechea; J Alfredo Martínez
Journal:  Obesity (Silver Spring)       Date:  2009-02-19       Impact factor: 5.002

8.  Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation.

Authors:  Sophia J Docherty; Oliver S P Davis; Claire M A Haworth; Robert Plomin; Jonathan Mill
Journal:  Epigenetics Chromatin       Date:  2009-03-10       Impact factor: 4.954

9.  Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.

Authors:  Kazuhiko Kotani; Naoki Sakane; Yoshiko Sano; Kokoro Tsuzaki; Yukiyo Matsuoka; Kahori Egawa; Makiko Yoshimura; Chika Horikawa; Yoshinori Kitagawa; Yoshinobu Kiso; Satoshi Kimura; John Schulze; Jennifer Taing; Alejandro Gugliucci
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

10.  Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.

Authors:  Feng Miao; David D Smith; Lingxiao Zhang; Andrew Min; Wei Feng; Rama Natarajan
Journal:  Diabetes       Date:  2008-09-05       Impact factor: 9.461

View more
  9 in total

1.  Molecular mechanisms underlying application of serum procalcitonin and stool miR-637 in prognosis of acute ischemic stroke.

Authors:  You-Mei Li; Xue-Yuan Liu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 2.  Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.

Authors:  Nina Holland; Daneida Lizarraga; Karen Huen
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

Review 3.  The Relationship between Cancer and Paraoxonase 1.

Authors:  Irma Martha Medina-Díaz; Néstor Ponce-Ruíz; Aurora Elizabeth Rojas-García; José Francisco Zambrano-Zargoza; Yael Y Bernal-Hernández; Cyndia Azucena González-Arias; Briscia S Barrón-Vivanco; José Francisco Herrera-Moreno
Journal:  Antioxidants (Basel)       Date:  2022-03-31

4.  Possible Mediation by Methylation in Acute Inflammation Following Personal Exposure to Fine Particulate Air Pollution.

Authors:  Cuicui Wang; Renjie Chen; Min Shi; Jing Cai; Jingjin Shi; Changyuan Yang; Huichu Li; Zhijing Lin; Xia Meng; Cong Liu; Yue Niu; Yongjie Xia; Zhuohui Zhao; Haidong Kan; Clarice R Weinberg
Journal:  Am J Epidemiol       Date:  2018-03-01       Impact factor: 4.897

5.  DNA methylation profile of genes involved in inflammation and autoimmunity correlates with vascular function in morbidly obese adults.

Authors:  Mohamed M Ali; Dina Naquiallah; Maryam Qureshi; Mohammed Imaduddin Mirza; Chandra Hassan; Mario Masrur; Francesco M Bianco; Patrice Frederick; Giulianotti P Cristoforo; Antonio Gangemi; Shane A Phillips; Abeer M Mahmoud
Journal:  Epigenetics       Date:  2021-01-25       Impact factor: 4.528

Review 6.  The progress of research on histone methylation in ischemic stroke pathogenesis.

Authors:  Yaxin Su; Lei Zhang; Yao Zhou; Lei Ding; Li Li; Zhongcheng Wang
Journal:  J Physiol Biochem       Date:  2021-09-02       Impact factor: 4.158

Review 7.  How Dietary Factors Affect DNA Methylation: Lesson from Epidemiological Studies.

Authors:  Andrea Maugeri; Martina Barchitta
Journal:  Medicina (Kaunas)       Date:  2020-07-25       Impact factor: 2.430

Review 8.  Epigenetic regulation of inflammation in stroke.

Authors:  Gavin Yong-Quan Ng; Yun-An Lim; Christopher G Sobey; Thameem Dheen; David Yang-Wei Fann; Thiruma V Arumugam
Journal:  Ther Adv Neurol Disord       Date:  2018-04-26       Impact factor: 6.570

9.  The Role of DNA Methylation in Ischemic Stroke: A Systematic Review.

Authors:  Minyan Zeng; Juanying Zhen; Xiaodan Zheng; Hongyan Qiu; Xiaonan Xu; Jun Wu; Zhijian Lin; Jun Hu
Journal:  Front Neurol       Date:  2020-10-27       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.